APA (7th ed.) Citation

Beketova, T. V., Babak, V. V., & Suprun, M. D. (2021). The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic. IMA PRESS LLC.

Chicago Style (17th ed.) Citation

Beketova, T. V., V. V. Babak, and M. D. Suprun. The Course and Outcomes of COVID-19 in Patients with ANCA-associated Systemic Vasculitis, Receiving Biological Therapy (Rituximab, Mepolizumab): The Results of the First 8 Months of the Pandemic. IMA PRESS LLC, 2021.

MLA (9th ed.) Citation

Beketova, T. V., et al. The Course and Outcomes of COVID-19 in Patients with ANCA-associated Systemic Vasculitis, Receiving Biological Therapy (Rituximab, Mepolizumab): The Results of the First 8 Months of the Pandemic. IMA PRESS LLC, 2021.